Complexo Hospitalario Universitario A Coruña

Centro asistencial

Foto de Complexo Hospitalario Universitario A Coruña

Foto de Carl von Ossietzky University of Oldenburg

Carl von Ossietzky University of Oldenburg

Oldenburg, Alemania

Publicacións en colaboración con investigadores/as de Carl von Ossietzky University of Oldenburg (6)

2024

Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group
Clinical Microbiology and Infection

2022

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Clinical Lung Cancer, Vol. 23, Núm. 8, pp. 720-730

2021

Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Journal of Clinical Oncology

2018

Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer
New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039

Proxecto CRIS desenvolto en colaboración coa Fundación Dialnet (Universidad de La Rioja)